Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Statements (Details 4)

v2.4.0.6
Condensed Consolidating Financial Statements (Details 4) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sources (uses) of cash and cash equivalents    
Net cash provided by (used in) operating activities $ (26,624) $ 50,989
Investing activities:    
Capital expenditures (30,343) (20,105)
Acquisition, net of cash received   (11,584)
Net cash used in investing activities (30,343) (31,689)
Financing activities:    
Proceeds from issuance of debt 15,825  
Deferred acquisition payments (6,617)  
Payments of long-term debt (1,576) (4,084)
Net payments under other credit facilities   (3,153)
Proceeds from exercise of stock options 42 159
Debt issuance costs (275) (29)
Change in restricted cash   (36,497)
Net cash provided by (used in) financing activities 7,399 (43,604)
Net decrease in cash and cash equivalents (49,568) (24,304)
Effect of foreign currency fluctuations on cash (458) (584)
Cash and cash equivalents at beginning of fiscal period 210,521 152,051
Cash and cash equivalents at end of fiscal period 160,495 127,163
Parent
   
Sources (uses) of cash and cash equivalents    
Net cash provided by (used in) operating activities (9,510) 4,214
Investing activities:    
Capital expenditures   (1)
Net cash used in investing activities   (1)
Financing activities:    
Proceeds from issuance of debt 15,825  
Deferred acquisition payments (5,617)  
Payments of long-term debt   (4,084)
Proceeds from exercise of stock options 42 159
Debt issuance costs (275)  
Net cash provided by (used in) financing activities 9,975 (3,925)
Net decrease in cash and cash equivalents 465 288
Cash and cash equivalents at beginning of fiscal period 7,933 6,417
Cash and cash equivalents at end of fiscal period 8,398 6,705
Guarantor Subsidiaries
   
Sources (uses) of cash and cash equivalents    
Net cash provided by (used in) operating activities (48,750) 32,545
Investing activities:    
Capital expenditures (9,877) (11,505)
Acquisition, net of cash received   (11,584)
Net cash used in investing activities (9,877) (23,089)
Financing activities:    
Deferred acquisition payments (1,000)  
Debt issuance costs   (29)
Change in restricted cash   (36,497)
Net cash provided by (used in) financing activities (1,000) (36,526)
Net decrease in cash and cash equivalents (59,627) (27,070)
Cash and cash equivalents at beginning of fiscal period 178,205 119,326
Cash and cash equivalents at end of fiscal period 118,578 92,256
Non-Guarantor Subsidiaries
   
Sources (uses) of cash and cash equivalents    
Net cash provided by (used in) operating activities 31,636 14,230
Investing activities:    
Capital expenditures (20,466) (8,599)
Net cash used in investing activities (20,466) (8,599)
Financing activities:    
Payments of long-term debt (1,576)  
Net payments under other credit facilities   (3,153)
Net cash provided by (used in) financing activities (1,576) (3,153)
Net decrease in cash and cash equivalents 9,594 2,478
Effect of foreign currency fluctuations on cash (458) (584)
Cash and cash equivalents at beginning of fiscal period 24,383 26,308
Cash and cash equivalents at end of fiscal period $ 33,519 $ 28,202